Breaking News

Yesterday Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Conference/Events	Cantor Fitzgerald biotech to hold analyst/industry dinner meeting » 16:34 06/02/23 06/02 16:34 06/02/23 16:34 ASND Ascendis Pharma $91.27 / +3.36 (+3.82%) , ZYME Zymeworks $8.67 / +0.18 (+2.12%) , BCYC Bicycle Therapeutics $25.23 / +1.105 (+4.58%) , IOVA Iovance Biotherapeutics $8.80 / +0.07 (+0.80%) , KURA Kura Oncology $13.19 / -0.3 (-2.22%) , PFE Pfizer $38.36 / +0.325 (+0.85%) , ARVN Arvinas $23.24 / +1.505 (+6.92%) , RHHBY Roche $40.39 / +0.42 (+1.05%) , SNY Sanofi $51.01 / +0.59 (+1.17%) , AZN AstraZeneca $72.57 / -0.27 (-0.37%) , LLY Eli Lilly $441.99 / +5.515 (+1.26%) , ALXO ALX Oncology $8.34 / +0.965 (+13.09%) , PRTG Portage Biotech $3.64 / -0.07 (-1.89%) Biotech Analyst Watsek… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 16:34 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ZYME SNY RHHBY PFE LLY KURA IOVA BCYC AZN ASND ARVN ALXO ZYME Zymeworks $8.67 / +0.18 (+2.12%) 05/18/23 Zymeworks president, COO Neil Klompas departs 03/30/23 Zymeworks discloses $1.6M purchase of common stock by Ecor1 Capital 01/23/23 Zymeworks shareholder EcoR1 Capital buys $3.0M in company shares 01/19/23 Jazz Pharmaceuticals, Zymeworks report 84% survival for zanidatamab in mGEA SNY Sanofi $51.01 / +0.59 (+1.17%) 05/31/23 Sanofi announces new data on frexalimab, to present at 2023 CMSC 05/21/23 Regeneron, Sanofi present Dupixent late-breaking Phase 3 COPD results 05/18/23 Sanofi 'pleased' with Supreme Court's ruling on Amgen's asserted patent claims 05/18/23 Supreme Court upholds Sanofi PCSK9 drug patent victory over Amgen RHHBY Roche $40.39 / +0.42 (+1.05%) 05/17/23 Genentech announces fenebrutinib study met primary, secondary endpoint 05/09/23 Genentech announces FDA acceptance of Vabysmo sBLA 04/26/23 Roche reports CHMP recommends EU approval of fixed-duration Columvi 04/26/23 Zentalis enters agreements with Foundation Medicine, Roche PFE Pfizer $38.36 / +0.325 (+0.85%) 06/01/23 Pfizer announces results from Phase 3 program of REVISIT, ASSEMBLE studies 05/31/23 Pfizer says FDA approves RSV prevention vaccine 05/30/23 Seagen shareholders approve acquisition by Pfizer 05/30/23 Pfizer's marstacimab shows significant efficacy in Phase 3 hemophilia trial LLY Eli Lilly $441.99 / +5.515 (+1.26%) 05/26/23 Attorneys announce over $500M pact with Eli Lilly to settle class-action suit 05/23/23 Moderna, BioNTech other Covid vaccine makers jump amid China Covid scare 05/18/23 Eli Lilly announces detailed results from peresolimab study published in NEJM 05/03/23 Biogen slips after competitor Eli Lilly's Alzheimer's trial hits target KURA Kura Oncology $13.19 / -0.3 (-2.22%) 04/17/23 Kura reports preclinical data on use of farnesyl transferase inhibitors 02/09/23 Kura Oncology announces first patients dosed in Phase 2 trial of ziftomenib 01/24/23 Kura Oncology jumps 6% to $14.85 as FDA clears its IND application for KO-2806 01/24/23 Kura Oncology announces FDA clearance of IND application for KO-2806 IOVA Iovance Biotherapeutics $8.80 / +0.07 (+0.80%) 05/26/23 Iovance Biotherapeutics announces FDA acceptance of BLA of Lifileucel 03/24/23 Iovance Biotherapeutics completes BLA submission for lifileucel 03/10/23 Iovance says it does not hold deposits, securities at Silicon Valley Bank 01/23/23 Clinigen divests Proleukin to Iovance Biotherapeutics for GBP 166.7M BCYC Bicycle Therapeutics $25.23 / +1.105 (+4.58%) 05/11/23 Bicycle Therapeutics and Orano Med report radio-conjugate data results 05/10/23 Bicycle Therapeutics jumps 8% after Bayer oncology pact, milestone payment 05/10/23 Bicycle to receive $45M upfront, plus future milestones in Bayer oncology pact 04/03/23 Bicycle Therapeutics names Santiago Arroyo, M.D Chief Development Officer AZN AstraZeneca $72.57 / -0.27 (-0.37%) 06/02/23 AstraZeneca's IMFINZI plus chemo improved pathologic response in Phase III trial 06/02/23 AstraZeneca says Imfinzi plus chemotherapy showed clinical benefit in trial 06/01/23 AstraZeneca, Merck announce LYNPARZA + abiraterone approved for BRCAm cancer 06/01/23 Merck and AstraZeneca's Lynparza prostate cancer combination approved by FDA ASND Ascendis Pharma $91.27 / +3.36 (+3.82%) 05/31/23 Ascendis Pharma announces oncology program update 05/01/23 Ascendis Pharma receives FDA CRL for TransCon PTH in hypoparathyroidism 04/03/23 Ascendis Pharma falls 38% after disclosing FDA notice of deficiencies in NDA 04/03/23 Ascendis' Phase 1/2 initial trial results of TransCon accepted for ASCO 2023 ARVN Arvinas $23.24 / +1.505 (+6.92%) 05/05/23 Arvinas expects cash to fund requirements into 2026 04/03/23 Arvinas appoints Page as SVP, Global Head of Oncology Strategy, Program Leader 02/23/23 Arvinas expects cash to fund requirements into 2026 12/16/22 Arvinas appoints Everett Cunningham to board of directors ALXO ALX Oncology $8.34 / +0.965 (+13.09%) 05/11/23 ALX Oncology expects cash to fund operations through mid-2025 05/09/23 ALX Oncology announces first patient dosed in Phase 2 trial of evorpacept 04/25/23 ALX Oncology enters clinical trial collaboration with Sanofi 03/13/23 ALX Oncology, Quantum Leap dose first patient in I-SPY-P1 trial ASND ZYME BCYC IOVA KURA PFE ARVN RHHBY SNY AZN LLY ALXO PRTG ASND Ascendis Pharma $91.27 / +3.36 (+3.82%) 06/02/23 Wedbush Ascendis Pharma price target raised to $187 from $186 at Wedbush 05/08/23 Wedbush Ascendis Pharma added to Best Ideas List at Wedbush 04/28/23 Cantor Fitzgerald Ascendis Pharma price target raised to $152 from $142 at Cantor Fitzgerald 04/12/23 Morgan Stanley Ascendis Pharma price target lowered to $107 from $108 at Morgan Stanley ZYME Zymeworks $8.67 / +0.18 (+2.12%) 05/18/23 Citi Zymeworks price target raised to $18 from $17 at Citi 05/09/23 Stifel Zymeworks price target raised to $19 from $18 at Stifel 03/20/23 Wells Fargo Zymeworks coverage transferred at Wells Fargo with Overweight rating 03/10/23 Citi Zymeworks price target lowered to $17 from $21 at Citi BCYC Bicycle Therapeutics $25.23 / +1.105 (+4.58%) 01/04/23 EF Hutton Bicycle Therapeutics initiated with a Buy at EF Hutton 01/02/23 Barclays Barclays views GSK acquisition interest as positive for oncology stocks 11/10/22 Piper Sandler Bicycle Therapeutics price target raised to $48 from $37 at Piper Sandler 11/09/22 JMP Securities Bicycle Therapeutics price target lowered to $46 from $70 at JMP Securities IOVA Iovance Biotherapeutics $8.80 / +0.07 (+0.80%) 05/30/23 Wells Fargo Iovance upgraded to Overweight at Wells Fargo after lifileucel BLA accepted 05/30/23 Wells Fargo Iovance Biotherapeutics upgraded to Overweight from Equal Weight at Wells Fargo 05/30/23 Stifel Iovance Biotherapeutics price target raised to $24 from $21 at Stifel 05/29/23 Barclays Iovance news 'important clearing event' for shares, says Barclays KURA Kura Oncology $13.19 / -0.3 (-2.22%) 05/31/23 Barclays Barclays reveals two small cap ideas into ASCO conference 05/16/23 BTIG Kura Oncology initiated with a Buy at BTIG 05/11/23 Stifel Kura Oncology price target lowered to $24 from $25 at Stifel 04/17/23 H.C. Wainwright Kura Oncology data support KO-2806 combination studies, says H.C. Wainwright PFE Pfizer $38.36 / +0.325 (+0.85%) 05/23/23 Jefferies Jefferies says Pfizer oral GLP-1 safety and tolerability 'important to note' 05/22/23 Pfizer weight loss drug may be as effective, quicker than Ozempic, CNBC says 05/19/23 BofA AdComm support for Pfizer's infant RSV vaccine 'not surprising,' says BofA 05/16/23 Stifel Seagen likely to stay 'distanced' from deal price after FTC action, says Stifel ARVN Arvinas $23.24 / +1.505 (+6.92%) 05/08/23 Stifel Arvinas price target lowered to $72 from $75 at Stifel 03/18/23 Citi Arvinas price target raised to $77 from $72 at Citi 02/23/23 Capital One Arvinas remains one of the best biotechs to own, says Capital One 01/17/23 Truist Arvinas price target lowered to $65 from $100 at Truist RHHBY Roche $40.39 / +0.42 (+1.05%) 05/19/23 Piper Sandler Regeneron Q1 Eylea miss 'not about share, says Piper Sandler 05/08/23 Guggenheim Regeneron price target lowered to $935 from $960 at Guggenheim 04/10/23 BofA BofA questions relevance of Briumvi tracking to Q1 beat, says TG move 'overdone' 03/27/23 Barclays Roche downgraded to Equal Weight from Overweight at Barclays SNY Sanofi $51.01 / +0.59 (+1.17%) 05/04/23 Raymond James Kymera Therapeutics upgraded to Outperform from Market Perform at Raymond James 04/28/23 Deutsche Bank Sanofi downgraded to Sell from Hold at Deutsche Bank 04/28/23 Deutsche Bank Sanofi downgraded to Sell from Hold at Deutsche Bank AZN AstraZeneca $72.57 / -0.27 (-0.37%) 05/26/23 Argus AstraZeneca price target lowered to $80 from $85 at Argus 05/09/23 Berenberg AstraZeneca price target raised to 135 GBp from 124 GBp at Berenberg 04/28/23 JPMorgan AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at JPMorgan 04/13/23 Argus AstraZeneca price target raised to $85 from $75 at Argus LLY Eli Lilly $441.99 / +5.515 (+1.26%) 05/26/23 Wells Fargo Eli Lilly price target raised to $500 from $440 at Wells Fargo 05/24/23 BofA Eli Lilly price target raised to $500 from $450 at BofA 05/23/23 TD Cowen Eli Lilly price target raised to $500 from $430 at TD Cowen 05/19/23 JPMorgan JPMorgan places 'Negative Catalyst Watch' on Novartis into data ALXO ALX Oncology $8.34 / +0.965 (+13.09%) 03/14/23 UBS ALX Oncology price target lowered to $29 from $31 at UBS 03/10/23 H.C. Wainwright ALX Oncology price target lowered to $30 from $65 at H.C. Wainwright 11/09/22 Cantor Fitzgerald ALX Oncology price target lowered to $22 from $32 at Cantor Fitzgerald 11/09/22 H.C. Wainwright ALX Oncology price target lowered to $65 from $80 at H.C. Wainwright PRTG Portage Biotech $3.64 / -0.07 (-1.89%) 12/01/22 H.C. Wainwright Portage Biotech price target lowered to $21 from $22 at H.C. Wainwright 11/30/22 Cantor Fitzgerald Portage Biotech price target lowered to $18 from $26 at Cantor Fitzgerald 11/30/22 Oppenheimer Portage Biotech price target lowered to $18 from $26 at Oppenheimer 09/20/22 H.C. Wainwright Portage Biotech price target lowered to $22 from $32 at H.C. Wainwright ZYME SNY RHHBY PRTG PFE LLY KURA IOVA BCYC AZN ARVN ALXO ZYME Zymeworks $8.67 / +0.18 (+2.12%) 05/08/23 Zymeworks reports Q1 adjusted EPS (34c), consensus (54c) 03/07/23 Zymeworks reports Q4 EPS $4.65, consensus $4.84 SNY Sanofi $51.01 / +0.59 (+1.17%) 04/27/23 Sanofi confirms FY23 business EPS view of up low single digits at CER 04/27/23 Sanofi reports Q1 business EPS EUR 2.16, up 11.9% at CER 03/30/23 IGM Biosciences Sanofi sees FY23 revenue $3M, consensus $5.5M 02/03/23 Sanofi sees 2023 business EPS up at low single digit rate at CER RHHBY Roche $40.39 / +0.42 (+1.05%) 04/26/23 Roche confirms outlook for FY23 04/26/23 Roche reports Q1 group sales CHF 15.32B vs. CHF 16.45B last year 02/02/23 Roche reports FY22 core EPS CHF20.30 vs. CHF19.81 last year PRTG Portage Biotech $3.64 / -0.07 (-1.89%) 03/01/23 Portage Biotech reports Q4 EPS (44c), consensus (23c) PFE Pfizer $38.36 / +0.325 (+0.85%) 05/02/23 Pfizer backs FY23 adjusted EPS view $3.25-$3.45, consensus $3.36 05/02/23 Pfizer reports Q1 adjusted EPS $1.23, consensus 98c 03/15/23 Royalty Pharma raises FY23 adjusted cash receipt guidance to $2.85B-$2.95B 01/31/23 Pfizer sees FY23 adjusted EPS $3.25-$3.45, consensus $4.44 LLY Eli Lilly $441.99 / +5.515 (+1.26%) 04/27/23 Eli Lilly raises FY23 adjusted EPS view to $8.65-$8.85 from $8.35-$8.55 04/27/23 Eli Lilly reports Q1 EPS $1.62, consensus $1.73 04/26/23 Notable companies reporting before tomorrow's open KURA Kura Oncology $13.19 / -0.3 (-2.22%) 02/23/23 Kura Oncology reports Q4 EPS (49c), consensus (57c) IOVA Iovance Biotherapeutics $8.80 / +0.07 (+0.80%) 05/09/23 Iovance Biotherapeutics reports Q1 EPS (50c), consensus (74c) 02/28/23 Iovance Biotherapeutics reports Q4 EPS (64c), consensus (64c) BCYC Bicycle Therapeutics $25.23 / +1.105 (+4.58%) 05/04/23 Bicycle Therapeutics reports Q1 EPS ($1.30), consensus ($1.07) 02/28/23 Bicycle Therapeutics reports Q4 EPS ($1.01), consensus ($1.06) AZN AstraZeneca $72.57 / -0.27 (-0.37%) 04/27/23 AstraZeneca sees FY23 core EPS up high single to low double-digit percentage 04/27/23 AstraZeneca reports Q1 core EPS $1.92, consensus $1.07 02/09/23 AstraZeneca sees FY23 core EPS up high single to low double-digit percentage 02/09/23 AstraZeneca reports Q4 core EPS $1.38, consensus $1.35 ARVN Arvinas $23.24 / +1.505 (+6.92%) 05/05/23 Arvinas reports Q1 EPS ($1.54), consensus ($1.51) 02/23/23 Arvinas reports Q4 EPS ($1.56), consensus ($1.22) ALXO ALX Oncology $8.34 / +0.965 (+13.09%) 05/11/23 ALX Oncology reports Q1 EPS (74c), consensus (80c) SNY RHHBY PFE LLY AZN SNY Sanofi $51.01 / +0.59 (+1.17%) 04/12/23 Sanders to call CEOs of largest insulin makers to testify, STAT says 01/30/23 Sanofi plans to lay off staff at vaccine factories in India, Reuters says 01/23/23 CytoReason to license IBD disease model to Sanofi 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports RHHBY Roche $40.39 / +0.42 (+1.05%) 05/10/23 BioNTech data was reported in June 2022, Reuters reports 01/11/23 Roche looks internally for pharmaceutical unit chief, Bloomberg reports PFE Pfizer $38.36 / +0.325 (+0.85%) 05/26/23 Health authorities to target next COVID shot to new strain, WSJ says 05/23/23 China's new Covid surge could result in 65M infections a week, Bloomberg says 05/14/23 Pfizer Pfizer, Stryker have strong growth prospects, Barron's says 05/10/23 BioNTech pancreatic cancer vaccine 'shows promise' in small trial, NYT says LLY Eli Lilly $441.99 / +5.515 (+1.26%) 04/24/23 Novo Nordisk, Lilly lobby for Medicare coverage of weight-loss drug, WSJ report 04/11/23 Drugmakers call for abortion pill ruling reversal, Reuters reports 04/10/23 Weight-loss business upended by popularity of ozempic, other drugs, WSJ reports AZN AstraZeneca $72.57 / -0.27 (-0.37%) 05/19/23 Astra China head says company seeks to 'love the Communist Party,' Reuters says 05/04/23 AstraZeneca chair says increasing CEO's pay wards of rivals, FT reports 04/06/23 GSK unit ordered to pay AstraZeneca royalties on Zejula sales, Reuters says ZYME SNY RHHBY PFE LLY KURA IOVA AZN ASND ZYME Zymeworks $8.67 / +0.18 (+2.12%) 03/08/23 Fly Intel: Pre-market Movers 01/12/23 Fly Intel: After-Hours Movers 12/19/22 What You Missed On Wall Street On Monday 12/19/22 What You Missed On Wall Street This Morning SNY Sanofi $51.01 / +0.59 (+1.17%) 05/10/23 What Wall Street is saying about Disney ahead of earnings 03/23/23 What You Missed On Wall Street On Thursday 03/23/23 What You Missed On Wall Street This Morning 03/14/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations RHHBY Roche $40.39 / +0.42 (+1.05%) 01/23/23 Biotech Alert: Searches spiking for these stocks today 01/12/23 Meet ZyVersa: Fly exclusive interview with CEO Stephen Glover PFE Pfizer $38.36 / +0.325 (+0.85%) 05/16/23 What You Missed On Wall Street On Tuesday 05/02/23 What You Missed On Wall Street On Tuesday 05/02/23 What You Missed On Wall Street This Morning 03/21/23 What You Missed On Wall Street On Tuesday LLY Eli Lilly $441.99 / +5.515 (+1.26%) 05/03/23 What You Missed On Wall Street On Wednesday 05/03/23 What You Missed On Wall Street This Morning 05/03/23 Fly Intel: Pre-market Movers 04/27/23 What You Missed On Wall Street On Thursday KURA Kura Oncology $13.19 / -0.3 (-2.22%) 05/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/21/23 Biotech Alert: Searches spiking for these stocks today IOVA Iovance Biotherapeutics $8.80 / +0.07 (+0.80%) 06/02/23 Biotech Alert: Searches spiking for these stocks today 06/01/23 Biotech Alert: Searches spiking for these stocks today 05/30/23 What You Missed On Wall Street On Tuesday 05/30/23 What You Missed On Wall Street This Morning AZN AstraZeneca $72.57 / -0.27 (-0.37%) 04/11/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/05/23 What You Missed On Wall Street On Wednesday 04/05/23 What You Missed On Wall Street This Morning 02/09/23 What You Missed On Wall Street This Morning ASND Ascendis Pharma $91.27 / +3.36 (+3.82%) 05/04/23 Biotech Alert: Searches spiking for these stocks today 05/03/23 Biotech Alert: Searches spiking for these stocks today 04/06/23 Biotech Alert: Searches spiking for these stocks today 04/05/23 Biotech Alert: Searches spiking for these stocks today 06/02/23 Biotechnology--Pre-ASCO Reception 06/12/23 Biotech/Biopharma 06/28/23 Biotech/Biopharma 06/28/23 Biotech/Biopharma 08/02/23 Biotech/Biopharma 06/02/23 2023 ASCO Annual Meeting 06/02/23 Truist Hosted Company Events at 2023 ASCO Annual Meeting 08/08/23 Eli Lilly - LLY 07/01/23 PDUFA Date for Glofitamab 11/25/23 PDUFA Date for Lifileucel 12/22/23 PDUFA Date for Eplontersen 06/06/23 Iovance Biotherapeutics, Inc. 06/12/23 Kura Oncology 06/15/23 Arvinas, Inc. 06/16/23 ALX Oncology Holdings Inc. 06/27/23 Bicycle Therapeutics PFE LLY AZN PFE Pfizer $38.36 / +0.325 (+0.85%) 05/24/23 Notable open interest changes for May 24th 05/23/23 Unusually active option classes on open May 23rd 05/23/23 Notable open interest changes for May 23rd 05/23/23 Unusual call flow in option market yesterday LLY Eli Lilly $441.99 / +5.515 (+1.26%) 03/13/23 Early notable gainers among liquid option names on March 13th 03/10/23 Early notable gainers among liquid option names on March 10th AZN AstraZeneca $72.57 / -0.27 (-0.37%) 05/26/23 Unusually active option classes on open May 26th 05/18/23 Unusually active option classes on open May 18th 05/09/23 AstraZeneca put volume heavy and directionally bearish 04/27/23 Unusually active option classes on open April 27th
Conference/Events	Kura Oncology to host investor day » 16:27 06/02/23 06/02 16:27 06/02/23 16:27 KURA Kura Oncology $13.19 / -0.3 (-2.22%) Investor Day to be held… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 5th, 16:27 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events KURA Kura Oncology $13.19 / -0.3 (-2.22%) 04/17/23 Kura reports preclinical data on use of farnesyl transferase inhibitors 02/09/23 Kura Oncology announces first patients dosed in Phase 2 trial of ziftomenib 01/24/23 Kura Oncology jumps 6% to $14.85 as FDA clears its IND application for KO-2806 01/24/23 Kura Oncology announces FDA clearance of IND application for KO-2806 KURA Kura Oncology $13.19 / -0.3 (-2.22%) 05/31/23 Barclays Barclays reveals two small cap ideas into ASCO conference 05/16/23 BTIG Kura Oncology initiated with a Buy at BTIG 05/11/23 Stifel Kura Oncology price target lowered to $24 from $25 at Stifel 04/17/23 H.C. Wainwright Kura Oncology data support KO-2806 combination studies, says H.C. Wainwright KURA Kura Oncology $13.19 / -0.3 (-2.22%) 02/23/23 Kura Oncology reports Q4 EPS (49c), consensus (57c) KURA Kura Oncology $13.19 / -0.3 (-2.22%) 05/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/21/23 Biotech Alert: Searches spiking for these stocks today 06/12/23 Biotech/Biopharma
Hot Stocks	Neurocrine presents data from long term use of INGREZZA » 08:32 06/02/23 06/02 08:32 06/02/23 08:32 NBIX Neurocrine $91.11 / +1.59 (+1.78%) Neurocrine Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NBIX Neurocrine $91.11 / +1.59 (+1.78%) 05/19/23 Neurocrine: Results from Phase 3 KINECT-HD study published in The Lancet 05/15/23 Neurocrine presents results of Ingrezza capsules in dyskinesia and schizophrenia 05/12/23 Neurocrine to present new analysis of Phase 2 data of crinecerfont in adults 05/03/23 Neurocrine chief HR officer Cooke sells 11,397 common shares NBIX Neurocrine $91.11 / +1.59 (+1.78%) 05/04/23 Canaccord Neurocrine price target lowered to $130 from $132 at Canaccord 05/04/23 Mizuho Neurocrine price target lowered to $111 from $116 at Mizuho 05/04/23 Guggenheim Guggenheim upgrades Neurocrine to Buy on Ingrezza strength, pipeline potential 05/04/23 Citi Neurocrine price target lowered to $122 from $127 at Citi NBIX Neurocrine $91.11 / +1.59 (+1.78%) 05/03/23 Neurocrine reports Q1 adjusted EPS (51c), consensus 13c 02/06/23 Neurocrine reports Q4 non-GAAP EPS $1.24, consensus $1.14 NBIX Neurocrine $91.11 / +1.59 (+1.78%) 05/04/23 What You Missed On Wall Street On Thursday 05/04/23 What You Missed On Wall Street This Morning 05/04/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/03/23 What You Missed On Wall Street On Friday 08/20/23 PDUFA Date for Valbenazine

Thursday
Recommendations	Wells says Coherus' Humira biosimilar pricing 'actually good news' for AbbVie » 11:12 06/01/23 06/01 11:12 06/01/23 11:12 ABBV AbbVie $132.40 / -5.575 (-4.04%) , CHRS Coherus Biosciences $4.09 / +0.005 (+0.12%) , AMGN Amgen $214.38 / -6.35 (-2.88%) Wells Fargo analyst Mohit… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options CHRS AMGN ABBV CHRS Coherus Biosciences $4.09 / +0.005 (+0.12%) 06/01/23 Coherus announces plans to offer Mark Cuban Cost Plus customers YUSIMRY 06/01/23 Coherus plans to launch YUSIMRY with lowest list price of adalimumab in US 05/31/23 Coherus plans to submit response to FDA on toripalimab site in early June AMGN Amgen $214.38 / -6.35 (-2.88%) 05/18/23 Sanofi 'pleased' with Supreme Court's ruling on Amgen's asserted patent claims 05/18/23 Regeneron 'applauds' Supreme Court's striking down Amgen's patent claims 05/18/23 Supreme Court upholds Sanofi PCSK9 drug patent victory over Amgen 05/18/23 Supreme Court upholds Sanofi patent victory over Amgen ABBV AbbVie $132.40 / -5.575 (-4.04%) 06/01/23 AbbVie slides as Coherus plans 'lowest list price' Humira biosimilar 06/01/23 AstraZeneca discontinues brazikumab IBD development program 05/31/23 AbbVie announces SLEek study meets primary, key secondary endpoints 05/25/23 AbbVie's upadacitinib Phase 3 results featured in NEJM publication ABBV CHRS AMGN ABBV AbbVie $132.40 / -5.575 (-4.04%) 05/02/23 Oppenheimer Vertex Pharmaceuticals price target raised to $410 from $350 at Oppenheimer 04/28/23 Guggenheim AbbVie price target lowered to $171 from $172 at Guggenheim 04/28/23 Wells Fargo AbbVie price target lowered to $195 from $200 at Wells Fargo 04/12/23 Barclays AbbVie price target raised to $160 from $155 at Barclays CHRS Coherus Biosciences $4.09 / +0.005 (+0.12%) 05/23/23 Barclays Coherus Biosciences price target lowered to $8 from $13 at Barclays 05/12/23 Maxim Coherus Biosciences price target lowered to $12 from $15 at Maxim 05/09/23 H.C. Wainwright Coherus Biosciences price target lowered to $24 from $26 at H.C. Wainwright 05/01/23 Truist Coherus Biosciences initiated with a Buy at Truist AMGN Amgen $214.38 / -6.35 (-2.88%) 05/16/23 Stifel Seagen likely to stay 'distanced' from deal price after FTC action, says Stifel 05/16/23 Jefferies Jefferies thinks Amgen-Horizon deal still gets done after 'speed bump' 05/03/23 Mizuho Amgen price target raised to $214 from $208 at Mizuho CHRS AMGN ABBV CHRS Coherus Biosciences $4.09 / +0.005 (+0.12%) 05/08/23 Coherus Biosciences reports Q1 EPS (75c), consensus (57c) 03/06/23 Coherus Biosciences reports Q4 EPS (60c), consensus (84c) AMGN Amgen $214.38 / -6.35 (-2.88%) 04/27/23 Amgen raises FY23 adjusted EPS view to $17.60-$18.70 from $17.40-$18.60 04/27/23 Amgen reports Q1 adjusted EPS $3.98, consensus $3.85 04/27/23 Notable companies reporting after market close 03/01/23 Horizon Therapeutics reports Q4 EPS $1.21, consensus $1.09 ABBV AbbVie $132.40 / -5.575 (-4.04%) 04/27/23 AbbVie raises FY23 adjusted EPS view to $10.72-$11.12 from $10.62-$11.02 04/27/23 AbbVie reports Q1 adjusted EPS $2.46, consensus $2.46 04/26/23 Notable companies reporting before tomorrow's open 16 May CHRS AMGN ABBV CHRS Coherus Biosciences $4.09 / +0.005 (+0.12%) 04/14/23 FDA resuming China lab inspections could benefit Amicus, BeiGene, Barron's says AMGN Amgen $214.38 / -6.35 (-2.88%) 05/23/23 Amgen, J&J settle patent lawsuit over Stelara biosimilar, Reuters reports 05/17/23 Regeneron CEO backs regulators attempt to block Amgen deal, FT reports 05/16/23 FTC will sue to block Horizon Therapeutics takeover by Amgen, Bloomberg says 05/15/23 FTC looks to block Horizon Therapeutics deal with Amgen, Capitol Forum says ABBV AbbVie $132.40 / -5.575 (-4.04%) 05/16/23 Muddy Waters short Chinook, says atrasentan 'highly unlikely' to be approved 04/17/23 Allergan Aesthetics' CoolSculpting can lead to disfigurement, NY Times reports 02/06/23 AbbVie looking for next hit drug after competitors target Humira, WSJ reports 01/31/23 AbbVie's Humira drug faces competition in the U.S., FT reports CHRS AMGN ABBV CHRS Coherus Biosciences $4.09 / +0.005 (+0.12%) 05/15/23 Fly Intel: After-Hours Movers 05/09/23 What You Missed On Wall Street On Tuesday 05/09/23 What You Missed On Wall Street This Morning 05/08/23 Fly Intel: After-Hours Movers AMGN Amgen $214.38 / -6.35 (-2.88%) 05/16/23 What You Missed On Wall Street On Tuesday 05/16/23 What You Missed On Wall Street This Morning 05/16/23 Fly Intel: Pre-market Movers 04/27/23 Fly Intel: After-Hours Movers ABBV AbbVie $132.40 / -5.575 (-4.04%) 04/27/23 What You Missed On Wall Street On Thursday 04/27/23 What You Missed On Wall Street This Morning 04/27/23 Fly Intel: Pre-market Movers 04/06/23 What You Missed On Wall Street On Thursday 06/28/23 Biotech/Biopharma 06/28/23 Biotech/Biopharma 06/02/23 2023 ASCO Annual Meeting 06/02/23 Truist Hosted Company Events at 2023 ASCO Annual Meeting 06/27/23 Coherus Biosciences - CHRS 06/07/23 Coherus Biosciences, Inc. AMGN ABBV AMGN Amgen $214.38 / -6.35 (-2.88%) 04/05/23 Early notable gainers among liquid option names on April 5th 02/17/23 Early notable gainers among liquid option names on February 17th 01/31/23 Amgen options imply 3.2% move in share price post-earnings ABBV AbbVie $132.40 / -5.575 (-4.04%) 05/24/23 AbbVie put volume heavy and directionally bearish 04/27/23 Unusually active option classes on open April 27th 02/09/23 Unusually active option classes on open February 9th 01/18/23 Unusually active option classes on open January 18th

Wednesday
Conference/Events	Halozyme management to meet with Evercore ISI » 06:23 05/31/23 05/31 06:23 05/31/23 06:23 HALO Halozyme $32.86 / -0.36 (-1.08%) Meeting to be held in New… Meeting to be held in New York on May 31 hosted by Evercore ISI. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events HALO Halozyme $32.86 / -0.36 (-1.08%) 03/15/23 Halozyme provides update on EPO decision regarding Darzalex 03/01/23 Halozyme director Henderson sells 20,000 common shares 01/10/23 Halozyme falls 7% to $52.00 after below-consensus FY23 guidance 01/10/23 Halozyme announces anticipated key events in 2023 HALO Halozyme $32.86 / -0.36 (-1.08%) 05/10/23 Piper Sandler Halozyme upgraded to Overweight from Neutral at Piper Sandler 03/27/23 Berenberg Halozyme resumed with a Buy at Berenberg 03/16/23 SVB Securities SVB Securities downgrades Halozyme to Market Perform given growth uncertainty 03/16/23 SVB Securities Halozyme downgraded to Market Perform from Outperform at SVB Securities HALO Halozyme $32.86 / -0.36 (-1.08%) 05/09/23 Halozyme sees FY23 non-GAAP EPS $2.50-$2.65, consensus $2.57 05/09/23 Halozyme reports Q1 non-GAAP EPS 47c, consensus 48c 03/15/23 Halozyme reaffirms FY23 revenue view $815M-$845M, consensus $829.01M 02/21/23 Halozyme sees FY23 adjusted EPS $2.50-$2.65, consensus $2.78 HALO Halozyme $32.86 / -0.36 (-1.08%) 03/27/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/16/23 What You Missed On Wall Street On Thursday 03/16/23 What You Missed On Wall Street This Morning 03/16/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/31/23 Halozyme
Recommendations	Barclays reveals two small cap ideas into ASCO conference » 05:55 05/31/23 05/31 05:55 05/31/23 05:55 RCUS Arcus Biosciences $20.26 / -1.71 (-7.78%) , KURA Kura Oncology $13.22 / -0.155 (-1.16%) Barclays reveled two… Barclays reveled two stock ideas going into this weekend's American Society of Clinical Oncology meeting: Arcus Biosciences (RCUS) and Kura Oncology (KURA). On Acrus, the analyst is positive on the stock's near-term risk/reward, including upcoming data, and sees an attractive valuation. The firm believes ASCO abstracts last week have helped shift the negative sentiment around anti-TIGIT. For Kura, Barclays is positive on the stock's near-term risk/reward and sees it potentially closing the gap versus Syndax. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events RCUS KURA RCUS Arcus Biosciences $20.26 / -1.71 (-7.78%) 05/26/23 Arcus Biosciences rises 25.4% 05/26/23 Arcus Biosciences rises 22.6% 05/26/23 Arcus Biosciences rises 20.6% 05/15/23 Arcus Biosciences jumps 2% amid expanded inflammation pact with Gilead KURA Kura Oncology $13.22 / -0.155 (-1.16%) 04/17/23 Kura reports preclinical data on use of farnesyl transferase inhibitors 02/09/23 Kura Oncology announces first patients dosed in Phase 2 trial of ziftomenib 01/24/23 Kura Oncology jumps 6% to $14.85 as FDA clears its IND application for KO-2806 01/24/23 Kura Oncology announces FDA clearance of IND application for KO-2806 RCUS KURA RCUS Arcus Biosciences $20.26 / -1.71 (-7.78%) 05/26/23 Citi Arcus Biosciences price target raised to $41 from $40 at Citi 03/09/23 Citi Arcus Biosciences price target lowered to $40 from $42 at Citi 12/21/22 Citi Arcus Biosciences selloff a buying opportunity, says Citi 12/21/22 Barclays Arcus Biosciences price target lowered to $36 from $60 at Barclays KURA Kura Oncology $13.22 / -0.155 (-1.16%) 05/16/23 BTIG Kura Oncology initiated with a Buy at BTIG 05/11/23 Stifel Kura Oncology price target lowered to $24 from $25 at Stifel 04/17/23 H.C. Wainwright Kura Oncology data support KO-2806 combination studies, says H.C. Wainwright 01/30/23 Stifel Kura Oncology initiated with a Buy at Stifel RCUS KURA RCUS Arcus Biosciences $20.26 / -1.71 (-7.78%) 05/09/23 Arcus Biosciences reports Q1 EPS ($1.09), consensus ($1.16) 02/28/23 Arcus Biosciences reports Q4 EPS (93c), consensus ($1.07) KURA Kura Oncology $13.22 / -0.155 (-1.16%) 02/23/23 Kura Oncology reports Q4 EPS (49c), consensus (57c) RCUS KURA RCUS Arcus Biosciences $20.26 / -1.71 (-7.78%) 12/20/22 What You Missed On Wall Street On Tuesday 12/20/22 What You Missed On Wall Street This Morning 12/19/22 Fly Intel: After-Hours Movers KURA Kura Oncology $13.22 / -0.155 (-1.16%) 05/17/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/21/23 Biotech Alert: Searches spiking for these stocks today 06/12/23 Biotech/Biopharma 06/02/23 2023 ASCO Annual Meeting 05/31/23 Kura Oncology, Inc. 06/15/23 Arcus Biosciences, Inc.

Tuesday
On The Fly	Fly Insider: Enviva, Diodes among week's notable insider trades » 15:31 05/30/23 05/30 15:31 05/30/23 15:31 ACAD Acadia Pharmaceuticals $23.73 / -1.055 (-4.26%) , SWX Southwest Gas $58.69 / +0.385 (+0.66%) , MODG Topgolf Callaway $17.28 / +0.155 (+0.91%) , EVA Enviva $8.88 / +0.33 (+3.86%) , ALGT Allegiant Travel $98.73 / -1.01 (-1.01%) , APTV Aptiv $90.97 / -1.17 (-1.27%) , BLNK Blink Charging $6.88 / -0.01 (-0.15%) , DIOD Diodes $92.29 / -3.63 (-3.78%) Welcome to "Fly Insider,"… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SWX MODG EVA BLNK APTV ALGT ACAD SWX Southwest Gas $58.69 / +0.385 (+0.66%) 05/15/23 Icahn bought Illumina in Q1, sold shares of Herc and Newell 03/28/23 Carl Icahn increases stake in Southwest Gas by $18.5M 03/23/23 Carl Icahn increases stake in Southwest Gas by $31.6M 03/14/23 Carl Icahn increases stake in Southwest Gas by $32M MODG Topgolf Callaway $17.28 / +0.155 (+0.91%) 05/22/23 Topgolf Callaway exec buys $113.6K in common stock 05/09/23 Topgolf Callaway CEO says FY23 guidance cut reflects near-term volatility 05/09/23 Topgolf Callaway falls 8% to $19.90 after cutting FY23 EPS outlook 01/06/23 Callaway Golf, Stephen Curry enter multi-year partnership extension EVA Enviva $8.88 / +0.33 (+3.86%) 05/08/23 Enviva rises 18.6% 05/05/23 Enviva rises 27.9% 05/04/23 Enviva falls -62.9% 05/04/23 Enviva trading resumes BLNK Blink Charging $6.88 / -0.01 (-0.15%) 05/16/23 Blink Charging commissions first battery to store energized DC 05/15/23 Blink Charging names Ritsaart van Montfrans as Chairman of the Board 05/05/23 Blink Charging partners with Amerit Fleet Solutions for maintenance support 05/03/23 Blink Charging names Brendan Jones as CEO APTV Aptiv $90.97 / -1.17 (-1.27%) 05/15/23 Appaloosa takes stake in FedEx, exits Aptiv 02/14/23 Appaloosa takes stake in Disney, exits position in Mosaic 12/23/22 Aptiv completes acquisition of Wind River from TPG 12/15/22 Aptiv appoints Benjamin Lyon as CTO ALGT Allegiant Travel $98.73 / -1.01 (-1.01%) 05/04/23 Allegiant Travel reaches agreement on a two-year extension with IBT 05/03/23 Allegiant raises FY23 EPS view for airline only to $9.00-$13.00 from $5.00-$9.00 04/13/23 Allegiant Travel reports March 2023 total system passengers up 0.7% y-o-y 03/17/23 Allegiant Travel reports February scheduled service passengers up 13% ACAD Acadia Pharmaceuticals $23.73 / -1.055 (-4.26%) 03/12/23 Acadia Pharmaceuticals announces FDA approval of DAYBUE for Rett syndrome ACAD SWX MODG EVA ALGT APTV BLNK DIOD ACAD Acadia Pharmaceuticals $23.73 / -1.055 (-4.26%) 05/22/23 BofA Acadia Pharmaceuticals price target raised to $26 from $23 at BofA 05/09/23 JMP Securities Acadia Pharmaceuticals price target raised to $23 from $22 at JMP Securities 05/09/23 Citi Acadia Pharmaceuticals price target raised to $21.60 from $21 at Citi SWX Southwest Gas $58.69 / +0.385 (+0.66%) 02/07/23 JPMorgan Southwest Gas price target lowered to $75 from $78 at JPMorgan 12/14/22 Wells Fargo Southwest Gas price target raised to $73 from $66 at Wells Fargo 11/30/22 BofA Southwest Gas downgraded to Neutral at BofA as strategic review 'drags on' 11/30/22 BofA Southwest Gas downgraded to Neutral from Buy at BofA MODG Topgolf Callaway $17.28 / +0.155 (+0.91%) 05/24/23 TD Cowen Topgolf Callaway price target lowered to $18 from $20 at TD Cowen 05/18/23 Compass Point Topgolf Callaway price target lowered to $34 from $37 at Compass Point 04/18/23 KeyBanc Topgolf Callaway coverage transitioned with an Overweight at KeyBanc 04/10/23 Jefferies Market 'yet to fully appreciate' Topgolf Callaway transformation, says Jefferies EVA Enviva $8.88 / +0.33 (+3.86%) 05/04/23 Truist Enviva downgraded to Sell from Buy at Truist 04/06/23 RBC Capital Enviva price target lowered to $32 from $63 at RBC Capital 04/04/23 Truist Enviva price target lowered to $40 from $70 at Truist 04/04/23 Citi Enviva price target lowered to $32 from $62 at Citi ALGT Allegiant Travel $98.73 / -1.01 (-1.01%) 05/15/23 Raymond James Allegiant Travel price target raised to $123 from $118 at Raymond James 05/04/23 Susquehanna Allegiant Travel price target raised to $105 from $90 at Susquehanna 05/01/23 BofA Allegiant Travel downgraded to Underperform from Neutral at BofA 03/10/23 Barclays Allegiant Travel downgraded to Equal Weight from Overweight at Barclays APTV Aptiv $90.97 / -1.17 (-1.27%) 05/17/23 Guggenheim Aptiv price target lowered to $138 from $152 at Guggenheim 05/08/23 Barclays Aptiv price target lowered to $135 from $142 at Barclays 05/05/23 Deutsche Bank Aptiv price target lowered to $128 from $136 at Deutsche Bank 05/05/23 TD Cowen Aptiv price target lowered to $141 from $144 at TD Cowen BLNK Blink Charging $6.88 / -0.01 (-0.15%) 05/12/23 Barclays Blink Charging price target lowered to $10 from $11 at Barclays 05/11/23 DA Davidson Blink Charging price target lowered to $11 from $14 at DA Davidson 05/08/23 B. Riley Blink Charging price target lowered to $8 from $14 at B. Riley 04/25/23 Stifel Blink Charging price target lowered to $9 from $23 at Stifel DIOD Diodes $92.29 / -3.63 (-3.78%) 05/10/23 Wells Fargo Diodes price target lowered to $85 from $95 at Wells Fargo 02/08/23 Wells Fargo Diodes price target raised to $95 from $75 at Wells Fargo 02/07/23 Truist Diodes price target raised to $108 from $101 at Truist 02/07/23 TD Cowen Diodes price target raised to $110 from $95 at Cowen SWX MODG EVA DIOD BLNK APTV ALGT ACAD SWX Southwest Gas $58.69 / +0.385 (+0.66%) 05/09/23 Southwest Gas reports Q1 EPS $1.69, consensus $1.42 02/28/23 Southwest Gas reports Q4 adjusted EPS $1.16, consensus $1.58 MODG Topgolf Callaway $17.28 / +0.155 (+0.91%) 05/09/23 Topgolf Callaway sees Q2 revenue $1.17B-$1.195B, consensus $1.22B 05/09/23 Topgolf Callaway sees FY23 adjusted EPS 63c-69c, consensus 78c 05/09/23 Topgolf Callaway reports Q1 adjusted EPS 17c, consensus 16c 05/09/23 Topgolf Callaway reports Q1 EPS 13c, consensus 16c EVA Enviva $8.88 / +0.33 (+3.86%) 05/04/23 Enviva cuts 2023 adjusted EBITDA outlook to $200M-$250M from $305M-$355M 05/03/23 Enviva reports Q1 net loss ($116.8M) vs. ($45.3M) last year 03/01/23 Enviva sees FY23 adjusted EBITDA $305M-$335M 03/01/23 Enviva reports Q4 revenue $239.3M, consensus $422.3M DIOD Diodes $92.29 / -3.63 (-3.78%) 05/09/23 Diodes sees Q2 revenue $467M plus or minus 3%, consensus $480.55M 05/09/23 Diodes reports Q1 adjusted EPS $1.59, consensus $1.49 02/06/23 Diodes sees Q1 revenue $467M plus or minus 3%, consensus $466.93M 02/06/23 Diodes reports Q4 adjustedEPS $1.73, consensus $1.61 BLNK Blink Charging $6.88 / -0.01 (-0.15%) 05/09/23 Blink Charging sees FY23 revenue $100M-$110M, consensus $103.57M 05/09/23 Blink Charging reports Q1 EPS (53c), consensus (46c) 02/28/23 Blink Charging sees FY23 revenue $100M-$110M, consensus $91.57M 02/28/23 Blink Charging reports Q4 adjusted EPS (41c), consensus (48c) APTV Aptiv $90.97 / -1.17 (-1.27%) 05/04/23 Aptiv backs FY23 adjusted EPS view $4.00-$4.50, consensus $4.41 05/04/23 Aptiv reports Q1 adjusted EPS 91c, consensus 89c 02/02/23 Aptiv sees FY23 adjusted EPS $4.00-$4.50, consensus $4.73 02/02/23 Aptiv reports Q4 adjusted EPS $1.27, consensus $1.22 ALGT Allegiant Travel $98.73 / -1.01 (-1.01%) 05/16/23 Allegiant Travel reports April total system passengers down 0.1% y-o-y 05/03/23 Allegiant Travel reports Q1 EPS $3.04 ex items, consensus $2.30 02/01/23 Allegiant Travel sees FY23 airline EPS $9 02/01/23 Allegiant Travel reports Q4 adjusted EPS $3.17, consensus 69c ACAD Acadia Pharmaceuticals $23.73 / -1.055 (-4.26%) 05/08/23 Acadia Pharmaceuticals backs FY23 revenue view of $520M-$550M, consensus $556.5M 05/08/23 Acadia Pharmaceuticals reports Q1 EPS (27c), consensus (21c) 02/27/23 Acadia Pharmaceuticals sees FY23 revenue $520M-$550M, consensus $569.2M 02/27/23 Acadia Pharmaceuticals reports Q4 EPS (26c), consensus (24c) 08 Mar 07 Feb BLNK BLNK Blink Charging $6.88 / -0.01 (-0.15%) 02/10/23 DOT's coming EV charger rules may pressure Tesla to open network, Reuters says SWX MODG EVA BLNK APTV ALGT ACAD SWX Southwest Gas $58.69 / +0.385 (+0.66%) 03/23/23 Fly Intel: After-Hours Movers 03/20/23 Fly Insider: Southwest Gas, Pathward among week's notable insider trades 03/14/23 Fly Intel: After-Hours Movers MODG Topgolf Callaway $17.28 / +0.155 (+0.91%) 05/22/23 Fly Intel: After-Hours Movers 05/09/23 Fly Intel: After-Hours Movers 02/09/23 Fly Intel: After-Hours Movers EVA Enviva $8.88 / +0.33 (+3.86%) 05/05/23 Buy/Sell: Wall Street's top 10 stock calls this week 05/04/23 What You Missed On Wall Street On Thursday 05/04/23 What You Missed On Wall Street This Morning 01/20/23 Sell these stocks now, proven algorithm says BLNK Blink Charging $6.88 / -0.01 (-0.15%) 04/03/23 What You Missed This Week in EVs and Clean Energy 03/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/25/23 Short Report: Surprise GameStop profit spooks bears 03/06/23 What You Missed This Week in EVs and Clean Energy APTV Aptiv $90.97 / -1.17 (-1.27%) 02/22/23 Here's what Wall Street experts are saying about these EV names ahead of results 02/15/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations ALGT Allegiant Travel $98.73 / -1.01 (-1.01%) 05/01/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/06/23 Fly Insider Express, ServiceNow among week's notable insider trades 01/11/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations ACAD Acadia Pharmaceuticals $23.73 / -1.055 (-4.26%) 05/22/23 Biotech Alert: Searches spiking for these stocks today 05/31/23 51st Annual Technology, Media & Telecom Conference 05/31/23 Diodes 06/01/23 ACADIA Pharmaceuticals Inc 06/06/23 Topgolf Callaway Brands Corp 06/15/23 Enviva Inc. 06/21/23 Allegiant Travel Company MODG BLNK APTV ACAD MODG Topgolf Callaway $17.28 / +0.155 (+0.91%) 05/24/23 Topgolf Callaway Brands call volume above normal and directionally bullish 02/09/23 Topgolf Callaway Brands options imply 5.8% move in share price post-earnings 12/20/22 Unusually active option classes on open December 20th BLNK Blink Charging $6.88 / -0.01 (-0.15%) 05/23/23 Largest borrow rate increases among liquid names 05/22/23 Blink Charging call volume above normal and directionally bullish 05/15/23 Largest borrow rate increases among liquid names 05/09/23 Blink Charging call volume above normal and directionally bullish APTV Aptiv $90.97 / -1.17 (-1.27%) 02/14/23 Early notable gainers among liquid option names on February 14th 01/27/23 Early notable gainers among liquid option names on January 27th ACAD Acadia Pharmaceuticals $23.73 / -1.055 (-4.26%) 04/11/23 Largest borrow rate increases among liquid names
Options	Largest borrow rate increases among liquid names » 08:45 05/30/23 05/30 08:45 05/30/23 08:45 FRCB First Republic Bank / + , CIFR Cipher Mining $2.40 / +0.1 (+4.36%) , NKLA Nikola / + , RAIN Rain Oncology $1.10 / -0.04 (-3.51%) , RXDX Prometheus $198.53 / -0.07 (-0.04%) , MVST Microvast $1.37 / -0.045 (-3.19%) , ATOM Atomera $9.90 / +0.41 (+4.32%) , XBI SPDR S&P BIOTECH $84.26 / +0.75 (+0.90%) , JWN Nordstrom $16.03 / +0.82 (+5.39%) , RUM Rumble $9.56 / -0.36 (-3.63%) Latest data shows the… Latest data shows the largest indicative borrow rate increases among liquid option names include: First Republic Bank (FRCB) 42.75% +17.11, Cipher Mining (CIFR) 45.84% +11.33, Nikola (NKLA) 83.45% +5.61, Rain Therapeutics (RAIN) 15.69% +3.43, Prometheus Biosciences (RXDX) 3.67% +3.41, Microvast Holdings (MVST) 5.17% +2.44, Atomera (ATOM) 11.22% +2.23, SPDR S&P Biotech (XBI) 6.07% +2.07, Nordstrom (JWN) 4.68% +1.98, and Rumble (RUM) 37.69% +1.94. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options RXDX RUM RAIN NKLA MVST JWN FRCB CIFR ATOM RXDX Prometheus $198.53 / -0.07 (-0.04%) 05/16/23 Prometheus, Seagen slip after FTC sues to block Horizon acquisition 04/16/23 Fly Intel: Top five weekend stock stories 04/16/23 Merck acquires Prometheus Biosciences for $200 per share 12/07/22 Prometheus announces results for PRA023 in APOLLO-CD Phase 2 study RUM Rumble $9.56 / -0.36 (-3.63%) 05/18/23 Rumble launches alpha release of Creator Sponsorship Marketplace 05/16/23 Culper Research calls Rumble 'unraveling stock promotion', remains short 04/27/23 Rumble down 4% to $7.81 after Culper Research short report 04/12/23 Rumble partners with RNC to stream first GOP debate of 2024 primaries RAIN Rain Oncology $1.10 / -0.04 (-3.51%) 05/30/23 Rain Oncology cofounder Robert Doebele to assume role of CMO 05/30/23 Rain Oncology provides update, outlines priorities for milademetan program 05/22/23 Rain Oncology Phase 3 MANTRA trial did not meet primary endpoint 01/23/23 Rain Oncology announces publication of Phase 1 data of milademetan NKLA Nikola / + 05/25/23 Nikola under pressure after receiving delisting notice 05/24/23 Nikola encourages stockholders to vote for Proposal 2 05/09/23 Nikola shares plunge 15% after quarterly report, exit from European JV 05/09/23 Nikola: Coolidge Phase 2 assembly hall expansion on track for end of Q2 MVST Microvast $1.37 / -0.045 (-3.19%) 04/13/23 Microvast announces appointment of Isida Tushe as general counsel 03/15/23 Microvast selected by MAFI & TREPEL as battery supplier for EV tractors 12/07/22 Microvast secures contract to supply BESS to U.S. customer JWN Nordstrom $16.03 / +0.82 (+5.39%) 05/10/23 Nordstrom names Cathy Smith as CFO, effective May 29 04/17/23 Nordstrom appoints Eric Sprunk to Board of Directors 04/17/23 Tilly's names Laura Janney as EVP, Chief Merchandising Officer 04/14/23 Nordstrom appoints Jason Morris as Chief Technology and Information Officer FRCB First Republic Bank / + 05/25/23 CRE exposure may pressure ratings of regional banks, Fitch Ratings says CIFR Cipher Mining $2.40 / +0.1 (+4.36%) 05/01/23 Cipher Mining mines 406 bitcoin in April 03/20/23 Cipher names Patrick Kelly and Will Iwaschuk co- presidents, Stennett as CAO 01/10/23 Cipher Mining ends 2022 with 394 Bitcoin 12/20/22 Cipher Mining acquires additional new mining rigs for Odessa data center ATOM Atomera $9.90 / +0.41 (+4.32%) 04/26/23 Atomera jumps 40% to $7.32 after entering pact with STMicroelectronics 04/26/23 Atomera signs commercial license agreement with STMicroelectronics 03/12/23 Atomera says not materially impacted by Silicon Valley Bank closure 01/12/23 Atomera collaborates with Arizona State over semiconductor material advancement FRCB CIFR NKLA RAIN RXDX MVST ATOM XBI JWN RUM FRCB First Republic Bank / + CIFR Cipher Mining $2.40 / +0.1 (+4.36%) 04/25/23 Canaccord Cipher Mining initiated with a Buy at Canaccord 03/14/23 Cantor Fitzgerald Cipher Mining initiated with an Overweight at Cantor Fitzgerald 03/13/23 Cantor Fitzgerald Cipher Mining initiated with an Overweight at Cantor Fitzgerald 02/21/23 Needham Cipher Mining initiated with a Buy at Needham NKLA Nikola / + 05/10/23 TD Cowen TD Cowen downgrades Nikola to Market Perform on persistent liquidity overhang 05/09/23 TD Cowen Nikola downgraded to Market Perform from Outperform at TD Cowen 03/31/23 BTIG BTIG downgrades Nikola to Neutral after stock offering, expects further dilution 03/31/23 BTIG Nikola downgraded to Neutral from Buy at BTIG RAIN Rain Oncology $1.10 / -0.04 (-3.51%) 05/23/23 H.C. Wainwright Rain Oncology downgraded to Neutral from Buy at H.C. Wainwright 05/23/23 Oppenheimer Rain Oncology downgraded to Perform on Phase 3 failure at Oppenheimer 05/23/23 Citi Rain Oncology downgraded to Neutral from Buy at Citi 05/22/23 Oppenheimer Rain Oncology downgraded to Perform from Outperform at Oppenheimer RXDX Prometheus $198.53 / -0.07 (-0.04%) 05/10/23 Jefferies Prometheus downgraded to Hold from Buy at Jefferies 04/18/23 Wells Fargo Prometheus downgraded to Equal Weight from Overweight at Wells Fargo 04/18/23 RBC Capital Prometheus downgraded to Sector Perform from Outperform at RBC Capital 04/17/23 Credit Suisse Prometheus downgraded to Neutral from Outperform at Credit Suisse MVST Microvast $1.37 / -0.045 (-3.19%) 04/03/23 H.C. Wainwright Microvast initiated with a Buy at H.C. Wainwright 08/18/22 Oppenheimer Oppenheimer starts Microvast with Outperform, $8 price target 08/18/22 Oppenheimer Microvast initiated with an Outperform at Oppenheimer ATOM Atomera $9.90 / +0.41 (+4.32%) 04/27/23 Craig-Hallum Atomera price target raised to $17 from $13 at Craig-Hallum 11/10/22 Craig-Hallum Atomera price target lowered to $13 from $22 at Craig-Hallum XBI SPDR S&P BIOTECH $84.26 / +0.75 (+0.90%) JWN Nordstrom $16.03 / +0.82 (+5.39%) 05/25/23 Citi Nordstrom price target lowered to $17 from $20 at Citi 05/02/23 Barclays Nordstrom price target lowered to $14 from $16 at Barclays 03/08/23 Argus Nordstrom upgraded to Buy from Hold at Argus 03/03/23 Morgan Stanley Nordstrom assumed with an Underweight at Morgan Stanley RUM Rumble $9.56 / -0.36 (-3.63%) 05/16/23 DA Davidson Rumble price target lowered to $12 from $15 at DA Davidson 12/02/22 Oppenheimer Rumble initiated with a Perform at Oppenheimer RXDX RUM RAIN NKLA MVST JWN CIFR RXDX Prometheus $198.53 / -0.07 (-0.04%) 05/09/23 Prometheus reports Q1 EPS (86c), consensus (91c) 02/28/23 Prometheus reports Q4 EPS (90c), consensus (92c) RUM Rumble $9.56 / -0.36 (-3.63%) 05/16/23 Rumble reports Q1 EPS (14c) vs. (2c) last year 03/30/23 Rumble reports Q4 EPS 0c, two estimates (2c) RAIN Rain Oncology $1.10 / -0.04 (-3.51%) 05/11/23 Rain Oncology reports Q1 EPS (56c), consensus (61c) 03/09/23 Rain Oncology reports Q4 EPS (70c), consensus (56c) NKLA Nikola / + 05/09/23 Nikola reports Q1 adjusted EPS (26c), consensus (26c) 05/08/23 Notable companies reporting before tomorrow's open 02/23/23 Nikola reports Q4 adjusted EPS (37c), consensus (43c) MVST Microvast $1.37 / -0.045 (-3.19%) 05/09/23 Microvast sees Q2 revenue $63M-$67M 05/09/23 Microvast raises FY23 revenue view to $348M-$368M JWN Nordstrom $16.03 / +0.82 (+5.39%) 03/02/23 Nordstrom reports Q4 EPS 74c, consensus 66c 03/02/23 Nordstrom sees FY23 adjusted EPS $1.80-$2.20, consensus $1.93 03/02/23 Notable companies reporting after market close 01/19/23 Nordstrom cuts FY22 adjusted EPS view to $1.50-$1.70 from $2.30-$2.60 CIFR Cipher Mining $2.40 / +0.1 (+4.36%) 05/09/23 Cipher Mining reports Q1 adjusted EPS 3c, consensus (2c) 03/14/23 Cipher Mining reports FY22 adjusted EPS (26c) vs (4c) last year 31 Mar 09 Dec RUM NKLA MVST JWN FRCB RUM Rumble $9.56 / -0.36 (-3.63%) 04/27/23 Culper short Rumble, says unique user base 'fraction' of claimed size 04/27/23 Culper Research announces short position in Rumble 01/05/23 Bear Cave sees 'more problems' at Rumble NKLA Nikola / + 01/20/23 Nikola speculated by The Deal as 'attractive' to activist 12/01/22 Fuzzy Panda short Fisker, says 'asset-light' model really 'liability-heavy' MVST Microvast $1.37 / -0.045 (-3.19%) 05/23/23 U.S. DOE ends plans for $200M grant for Microvast, Reuters reports 02/16/23 DOE reviewing $200M grant to Microvast amid concerns, Bloomberg says JWN Nordstrom $16.03 / +0.82 (+5.39%) 04/19/23 Ryan Cohen pulls Nordstrom board candidates, Bloomberg reports 02/06/23 Nordstrom tells Fox open to Cohen views, hasn't sought talks in 'years' 02/02/23 Ryan Cohen amasses sizable stake in Nordstrom, WSJ reports FRCB First Republic Bank / + 05/25/23 JPMorgan informs some First Republic staff of layoffs, Reuters says 05/24/23 DOJ probing trading by First Republic employees amid collapse, Bloomberg says 05/24/23 DOJ probing trading by First Republic employees amid collapse, Bloomberg says 05/05/23 SEC probing trades by First Republic executives, Bloomberg reports RXDX RUM RAIN NKLA MVST JWN FRCB CIFR ATOM RXDX Prometheus $198.53 / -0.07 (-0.04%) 05/16/23 What You Missed On Wall Street On Tuesday 04/19/23 Biotech Alert: Searches spiking for these stocks today 04/17/23 What You Missed On Wall Street This Morning 04/17/23 Fly Intel: Pre-market Movers RUM Rumble $9.56 / -0.36 (-3.63%) 03/31/23 Fly Intel: Pre-market Movers 03/30/23 Fly Intel: After-Hours Movers 01/05/23 What You Missed On Wall Street This Morning 12/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations RAIN Rain Oncology $1.10 / -0.04 (-3.51%) 05/23/23 What You Missed On Wall Street On Tuesday 05/23/23 What You Missed On Wall Street This Morning 05/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/22/23 What You Missed On Wall Street On Monday NKLA Nikola / + 05/15/23 What You Missed This Week in EVs and Clean Energy 05/10/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/09/23 What You Missed On Wall Street On Tuesday 05/09/23 Fly Intel: Pre-market Movers MVST Microvast $1.37 / -0.045 (-3.19%) 05/10/23 What You Missed On Wall Street On Wednesday 05/10/23 What You Missed On Wall Street This Morning 01/30/23 Here's what Wall St. experts are saying about these automakers ahead of earnings JWN Nordstrom $16.03 / +0.82 (+5.39%) 05/07/23 Short Report: Bears increase exposure to Lemonade after earnings-driven spike 04/02/23 Short Report: Bearish views on Lovesac remain elevated despite earnings beat 03/11/23 Buy/Sell: Wall Street's top 10 stock calls this week 03/08/23 What You Missed On Wall Street On Wednesday FRCB First Republic Bank / + 05/26/23 What You Missed On Wall Street On Friday 05/26/23 What You Missed On Wall Street This Morning 05/25/23 What You Missed On Wall Street On Thursday CIFR Cipher Mining $2.40 / +0.1 (+4.36%) 02/07/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations ATOM Atomera $9.90 / +0.41 (+4.32%) 04/26/23 Fly Intel: After-Hours Movers 06/02/23 2023 ASCO Annual Meeting 05/31/23 Nordstrom - JWN 05/31/23 Rain Oncology Inc. 06/06/23 Nordstrom Inc. 06/07/23 Nikola Corporation 06/15/23 Prometheus Biosciences, Inc. 06/16/23 Rumble Inc 07/10/23 Prometheus 07/11/23 Prometheus XBI RXDX RUM NKLA MVST JWN CIFR ATOM XBI SPDR S&P BIOTECH $84.26 / +0.75 (+0.90%) 04/21/23 Largest borrow rate increases among liquid names 01/27/23 Largest borrow rate increases among liquid names RXDX Prometheus $198.53 / -0.07 (-0.04%) 12/05/22 Prometheus Biosciences put volume heavy and directionally bearish RUM Rumble $9.56 / -0.36 (-3.63%) 05/26/23 Rumble put volume heavy and directionally bearish 05/24/23 Largest borrow rate increases among liquid names 05/15/23 Rumble options imply 10.0% move in share price post-earnings 05/10/23 Rumble call volume above normal and directionally bullish NKLA Nikola / + 05/22/23 Largest borrow rate increases among liquid names 05/19/23 Unusually active option classes on open May 19th 05/17/23 Largest borrow rate increases among liquid names 05/11/23 Largest borrow rate increases among liquid names MVST Microvast $1.37 / -0.045 (-3.19%) 05/16/23 Largest borrow rate increases among liquid names JWN Nordstrom $16.03 / +0.82 (+5.39%) 05/26/23 Largest borrow rate increases among liquid names 04/25/23 Nordstrom call volume above normal and directionally bullish 04/10/23 Nordstrom call volume above normal and directionally bullish 03/16/23 Nordstrom call volume above normal and directionally bullish CIFR Cipher Mining $2.40 / +0.1 (+4.36%) 05/19/23 Largest borrow rate increases among liquid names 05/18/23 Largest borrow rate increases among liquid names 02/17/23 Largest borrow rate increases among liquid names ATOM Atomera $9.90 / +0.41 (+4.32%) 05/15/23 Largest borrow rate increases among liquid names

Over a week ago
On The Fly	Biotech Alert: Searches spiking for these stocks today » 10:54 05/25/23 05/25 10:54 05/25/23 10:54 KRYS Krystal Biotech $117.51 / -1.31 (-1.10%) , BPMC Blueprint Medicines $55.95 / -2.01 (-3.47%) , RNA Avidity Biosciences $10.98 / -0.315 (-2.79%) , ACHV Achieve Life Sciences $6.03 / +0.02 (+0.33%) , OTLK Outlook Therapeutics $1.46 / -0.04 (-2.68%) These names in the… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events RNA OTLK KRYS BPMC ACHV RNA Avidity Biosciences $10.98 / -0.315 (-2.79%) 05/17/23 Avidity Biosciences: FDA eases partial clinical hold on AOC 1001 04/27/23 Avidity Biosciences announces data from MARINA clinical trial of AOC 1001 04/24/23 Avidity Biosciences granted FDA Fast Track designation to AOC 1044 03/30/23 Avidity Biosciences provides regulatory update on dystrophy candidate AOC 1001 OTLK Outlook Therapeutics $1.46 / -0.04 (-2.68%) 03/13/23 Outlook Therapeutics confirms no exposure to Silivon Valley Bank 02/14/23 Outlook Therapeutics announces anticipated milestones 02/14/23 Outlook sees cash runway through anticipated FDA approval of ONS-5010 01/19/23 Outlook Therapeutics appoints Surendra Sharma as SVP, medical affairs KRYS Krystal Biotech $117.51 / -1.31 (-1.10%) 05/23/23 Krystal Biotech director Janney sells 50,000 common shares 05/23/23 Option Care Health selected by Krystal Biotech as part of Vyjuvek distribution 05/22/23 Krystal Biotech sees cash runway through end of 2026 05/19/23 Krystal Biotech up 5% after receiving FDA approval for Vyjuvek BPMC Blueprint Medicines $55.95 / -2.01 (-3.47%) 05/23/23 Blueprint Medicines announces publication of results from PIONEER Trial 05/22/23 Blueprint Medicines announces FDA approval of AYVAKIT from treatment of SM 05/22/23 Blueprint Medicines' Ayvakit gets expanded approval for ISM 04/26/23 Blueprint Medicines to present new clinical data at 2023 ASCO meeting ACHV Achieve Life Sciences $6.03 / +0.02 (+0.33%) 05/23/23 Achieve Life Sciences' cytisinicline shows smoking cessation benefit in trial 05/17/23 Achieve Life Sciences refinances loan with Silicon Valley Bank 04/20/23 Achieve Life Sciences announces Phase 2 ORCA-V1 trial results 03/30/23 Achieve Life Sciences announces board refresh KRYS BPMC RNA ACHV OTLK KRYS Krystal Biotech $117.51 / -1.31 (-1.10%) 05/25/23 BofA Krystal Biotech price target raised to $140 from $118 at BofA 05/24/23 Alliance Global Partners Abeona 'well positioned' for potential EB-101 approval, says Alliance Global 05/24/23 Stifel Krystal Biotech price target raised to $145 from $102 at Stifel 05/22/23 Guggenheim Krystal Biotech price target raised to $130 from $101 at Guggenheim BPMC Blueprint Medicines $55.95 / -2.01 (-3.47%) 05/23/23 Guggenheim Blueprint Medicines price target raised to $82 from $78 at Guggenheim 05/23/23 H.C. Wainwright Blueprint Medicines price target raised to $85 from $75 at H.C. Wainwright 05/23/23 Barclays Blueprint Medicines price target raised to $46 from $44 at Barclays 05/05/23 H.C. Wainwright Blueprint Medicines price target raised to $75 from $70 at H.C. Wainwright RNA Avidity Biosciences $10.98 / -0.315 (-2.79%) 05/22/23 Evercore ISI Avidity Biosciences upgraded to Outperform from In Line at Evercore ISI 05/11/23 Wells Fargo Avidity Biosciences price target lowered to $50 from $55 at Wells Fargo 03/31/23 Evercore ISI Avidity Biosciences downgraded to In Line at Evercore on safety concerns 03/31/23 Evercore ISI Avidity Biosciences downgraded to In Line from Outperform at Evercore ISI ACHV Achieve Life Sciences $6.03 / +0.02 (+0.33%) 11/16/22 Maxim Achieve Life Sciences price target lowered to $8 from $21 at Maxim 11/15/22 Oppenheimer Achieve Life Sciences price target lowered to $20 from $27 at Oppenheimer OTLK Outlook Therapeutics $1.46 / -0.04 (-2.68%) 04/03/23 Guggenheim Guggenheim starts Outlook Therapeutics at Buy on Lytenava opportunity 04/03/23 Guggenheim Outlook Therapeutics initiated with a Buy at Guggenheim 02/06/23 Cantor Fitzgerald Outlook Therapeutics initiated with an Overweight at Cantor Fitzgerald 10/31/22 BTIG Outlook Therapeutics initiated with a Buy at BTIG RNA OTLK KRYS BPMC ACHV RNA Avidity Biosciences $10.98 / -0.315 (-2.79%) 05/09/23 Avidity Biosciences reports Q1 EPS (74c), consensus (85c) 02/28/23 Avidity Biosciences reports Q4 EPS (88c), consensus (89c) OTLK Outlook Therapeutics $1.46 / -0.04 (-2.68%) 05/15/23 Outlook Therapeutics reports Q2 EPS (3c), consensus (6c) 02/14/23 Outlook Therapeutics reports Q1 EPS (8c), consensus (5c) 12/29/22 Outlook Therapeutics reports 2022 EPS (31c), consensus (31c) KRYS Krystal Biotech $117.51 / -1.31 (-1.10%) 05/08/23 Krystal Biotech reports Q1 EPS ($1.76), consensus ($1.44) 02/27/23 Krystal Biotech reports Q4 EPS ($1.25), consensus ($1.32) BPMC Blueprint Medicines $55.95 / -2.01 (-3.47%) 05/04/23 Blueprint Medicines reports Q1 EPS ($2.15), consensus ($2.67) 02/16/23 Blueprint Medicines reports Q4 EPS ($2.65), consensus ($2.65) ACHV Achieve Life Sciences $6.03 / +0.02 (+0.33%) 05/09/23 Achieve Life Sciences reports Q1 EPS (50c), consensus (69c) 03/16/23 Achieve Life Sciences reports Q4 EPS (83c), consensus (83c) 16 Dec RNA RNA Avidity Biosciences $10.98 / -0.315 (-2.79%) 04/11/23 Drugmakers call for abortion pill ruling reversal, Reuters reports RNA KRYS BPMC ACHV RNA Avidity Biosciences $10.98 / -0.315 (-2.79%) 04/28/23 What You Missed On Wall Street On Friday 04/28/23 What You Missed On Wall Street This Morning 03/31/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/30/23 What You Missed On Wall Street On Thursday KRYS Krystal Biotech $117.51 / -1.31 (-1.10%) 05/24/23 Biotech Alert: Searches spiking for these stocks today 05/22/23 Biotech Alert: Searches spiking for these stocks today 04/06/23 Fly Intel: After-Hours Movers 02/28/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BPMC Blueprint Medicines $55.95 / -2.01 (-3.47%) 05/22/23 Fly Intel: After-Hours Movers 03/28/23 Fly Intel: After-Hours Movers ACHV Achieve Life Sciences $6.03 / +0.02 (+0.33%) 01/12/23 Biotech Alert: Searches spiking for these stocks today 08/02/23 Biotech/Biopharma 06/02/23 2023 ASCO Annual Meeting 07/11/23 Outlook Therapeutics - OTLK 08/29/23 PDUFA Date for ONS-5010/Lytenava 06/07/23 Achieve Life Sciences, Inc. 06/15/23 Avidity Biosciences, Inc. 06/21/23 Blueprint Medicines Corp.
Hot Stocks	MannKind appoints Blank as EVP, Research & Development, CMO » 08:34 05/24/23 05/24 08:34 05/24/23 08:34 MNKD MannKind $4.65 / -0.145 (-3.02%) MannKind announced… MannKind announced Burkhard Blank, MD, has joined the company as Executive Vice President, EVP, Research & Development and Chief Medical Officer, CMO, effective today. Blank will report directly to Michael Castagna, PharmD, Chief Executive Officer, and will serve on the company's executive leadership team. Dr. Blank recently served as CMO/Head of R&D at Pharnext SA after serving seven years in the same position at Acorda Therapeutics. ShowHide Related Items >><< Company News Street Research Earnings Events MNKD MannKind $4.65 / -0.145 (-3.02%) 02/22/23 MannKind to present results from study of inhaled Technosphere Insulin 01/23/23 MannKind says clofazimine inhalation suspension to advance to Phase 2/3 study MNKD MannKind $4.65 / -0.145 (-3.02%) 02/27/23 H.C. Wainwright MannKind price target raised to $7 from $6 at H.C. Wainwright MNKD MannKind $4.65 / -0.145 (-3.02%) 05/09/23 MannKind reports Q1 EPS (4c), consensus (5c) 05/25/23 MannKind Corp.

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial